Table 1.

Development of nasal obstruction assessed by patients on days 3, 6, 9, and 12 following treatment with ectoine nasal spray.

	d3	d6	d9	d12	P (d3 versus d12)
Study 1	2.74 ± 2.31	2.52 ± 2.18	2.10 ± 2.00	1.64 ± 1.68	<0.001
Study 2	3.67 ± 2.28	2.80 ± 1.99	2.33 ± 1.65	1.87 ± 1.33	<0.001